Irving Magee Investment Management’s West Pharmaceutical WST Stock Holding History

Irving Magee Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-41,588	Closed	-$3.39M	–	32
2017 Q1	$3.39M	Hold	41,588	–	–	1.31%	37
2016 Q4	$3.53M	Sell	41,588 -11	-0%	-$865	1.37%	37
2016 Q3	$3.1M	Sell	41,599 -28,543	-41%	-$2.27M	1.41%	33
2016 Q2	$5.32M	Hold	70,142	–	–	2.6%	9
2016 Q1	$4.86M	Sell	70,142 -195	-0.3%	-$11.7K	2.47%	15
2015 Q4	$4.24M	Sell	70,337 -68,000	-49%	-$4.09M	2.17%	17
2015 Q3	$7.49M	Hold	138,337	–	–	3.9%	5
2015 Q2	$8.04M	Hold	138,337	–	–	3.49%	6
2015 Q1	$8.33M	Hold	138,337	–	–	3.61%	4
2014 Q4	$7.37M	Buy	138,337 +59	+0%	+$2.95K	3.27%	7
2014 Q3	$6.19M	Hold	138,278	–	–	2.86%	9
2014 Q2	$5.83M	Hold	138,278	–	–	2.64%	10
2014 Q1	$6.09M	Hold	138,278	–	–	2.77%	7
2013 Q4	$6.78M	Hold	138,278	–	–	3.1%	6
2013 Q3	$5.69M	Hold	138,278	–	–	2.89%	8
2013 Q2	$4.86M	Buy	+138,278	New	+$4.55M	2.68%	11

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Irving Magee Investment Management's WST Position: Q2 2017 in Review

Irving Magee Investment Management sold out of West Pharmaceutical (WST) in Q2 2017, closing a stake of 41,588 shares — an estimated $3.39M sold.

Irving Magee Investment Management first reported a position in WST in Q2 2013 and held it in 16 quarters. The position peaked at $8.33M in Q1 2015. 309 funds tracked by Wall St. Rank hold WST as of Q2 2017.

Irving Magee Investment Management reported no remaining West Pharmaceutical position as of Q2 2017 after selling out during the quarter.
Irving Magee Investment Management sold 41,588 West Pharmaceutical shares in Q2 2017, an estimated $3.39M.
Irving Magee Investment Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 16 quarters.
Irving Magee Investment Management's West Pharmaceutical position peaked at $8.33M in Q1 2015.
309 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2017.

Based on Irving Magee Investment Management's 13F filing for Q2 2017.